share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  08/28 06:09
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-280683, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities under the Securities Act. This development could potentially pave the way for SeaStar Medical to raise capital through the sale of securities.
SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-280683, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities under the Securities Act. This development could potentially pave the way for SeaStar Medical to raise capital through the sale of securities.
SeaStar醫療控股公司已宣佈在2024年8月27日下午4:30時與美國證券交易委員會(SEC)提交的S-3表格生效。根據文件號333-280683,該申請對公司來說是一個重要的步驟,表明其已滿足發行證券的《證券法》的必要SEC要求。這一進展有潛力爲SeaStar醫療通過發行證券籌集資本。
SeaStar醫療控股公司已宣佈在2024年8月27日下午4:30時與美國證券交易委員會(SEC)提交的S-3表格生效。根據文件號333-280683,該申請對公司來說是一個重要的步驟,表明其已滿足發行證券的《證券法》的必要SEC要求。這一進展有潛力爲SeaStar醫療通過發行證券籌集資本。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息